New prostate cancer study aims to reduce treatment fatigue
NCT ID NCT06274047
Summary
This study is testing whether a personalized approach using the drug apalutamide can reduce fatigue and other side effects for men receiving radiation treatment after prostate cancer surgery. Researchers will compare apalutamide-based treatments against standard hormone therapy in 120 participants. The main goal is to see if this approach improves quality of life while still controlling the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Email: •••••@•••••
Contact
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Kansas Medical Center
RECRUITINGKansas City, Kansas, 66103, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.